These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34775400)

  • 1. Prognostic Significance of Lymphocyte-to-Monocyte and Platelet-to-Lymphocyte Ratio in Rectal Cancer: A Systematic Review, Meta-analysis, and Meta-regression.
    Hamid HKS; Emile SH; Davis GN
    Dis Colon Rectum; 2022 Feb; 65(2):178-187. PubMed ID: 34775400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis.
    Hamid HKS; Davis GN; Trejo-Avila M; Igwe PO; Garcia-Marín A
    Surg Oncol; 2021 Jun; 37():101556. PubMed ID: 33819850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implications of Pretreatment: Lymphocyte-to-Monocyte Ratio in Patients With Rectal Cancer Receiving Preoperative Chemoradiotherapy.
    Yamamoto A; Toiyama Y; Okugawa Y; Oki S; Ide S; Saigusa S; Araki T; Kusunoki M
    Dis Colon Rectum; 2019 Feb; 62(2):171-180. PubMed ID: 30451750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
    Wang P; Wang Z; Liu Y; Xie J; Ren Y
    Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis.
    Portale G; Bartolotta P; Azzolina D; Gregori D; Fiscon V
    Langenbecks Arch Surg; 2023 Feb; 408(1):85. PubMed ID: 36781510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can pretreatment blood biomarkers predict pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer?
    Morais M; Fonseca T; Machado-Neves R; Honavar M; Coelho AR; Lopes J; Barbosa E; Guerreiro E; Carneiro S
    Future Oncol; 2021 Dec; 17(35):4947-4957. PubMed ID: 34734533
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection.
    Portale G; Cavallin F; Valdegamberi A; Frigo F; Fiscon V
    J Gastrointest Surg; 2018 Sep; 22(9):1611-1618. PubMed ID: 29687424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of the lymphocyte-to-monocyte ratio in patients undergoing resection for nonmetastatic rectal cancer.
    Wu QB; Wang M; Hu T; He WB; Wang ZQ
    Medicine (Baltimore); 2016 Nov; 95(44):e4945. PubMed ID: 27858839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
    Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
    J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.
    Xia LJ; Li W; Zhai JC; Yan CW; Chen JB; Yang H
    BMC Cancer; 2020 Mar; 20(1):208. PubMed ID: 32164623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy.
    Zhang LN; Xiao W; OuYang PY; You K; Zeng ZF; Ding PR; Pan ZZ; Xu RH; Gao YH
    Tumour Biol; 2015 Sep; 36(10):8213-9. PubMed ID: 25994571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma.
    Ward WH; Goel N; Ruth KJ; Esposito AC; Lambreton F; Sigurdson ER; Meyer JE; Farma JM
    J Surg Res; 2018 Dec; 232():275-282. PubMed ID: 30463730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer.
    Kawai M; Hirono S; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Tanioka K; Yamaue H
    Surgery; 2019 Jun; 165(6):1151-1160. PubMed ID: 30765142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.
    Ertekin SS; Mangas C; Riquelme-Mc Loughlin C; Carrera C; Malvehy J; Puig S; Podlipnik S
    Acta Derm Venereol; 2024 Apr; 104():adv27571. PubMed ID: 38655656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery.
    Zhao J; Xu J; Zhang R
    Med Sci Monit; 2017 Oct; 23():4826-4833. PubMed ID: 28988257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
    Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Saigusa S; Tanaka K; Mohri Y; Kusunoki M
    Int Surg; 2015 Feb; 100(2):199-207. PubMed ID: 25692418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
    Ke TM; Lin LC; Huang CC; Chien YW; Ting WC; Yang CC
    Medicine (Baltimore); 2020 Apr; 99(17):e19877. PubMed ID: 32332656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
    Leng J; Wu F; Zhang L
    Front Oncol; 2022; 12():734948. PubMed ID: 35651788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.